These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9221801)

  • 1. Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.
    Talve L; Sauroja I; Collan Y; Punnonen K; Ekfors T
    Int J Cancer; 1997 Jun; 74(3):255-9. PubMed ID: 9221801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
    Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW
    Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma.
    Funk JO; Schiller PI; Barrett MT; Wong DJ; Kind P; Sander CA
    J Cutan Pathol; 1998 Jul; 25(6):291-6. PubMed ID: 9694617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.
    Piccinin S; Doglioni C; Maestro R; Vukosavljevic T; Gasparotto D; D'Orazi C; Boiocchi M
    Int J Cancer; 1997 Feb; 74(1):26-30. PubMed ID: 9036865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions.
    Keller-Melchior R; Schmidt R; Piepkorn M
    J Invest Dermatol; 1998 Jun; 110(6):932-8. PubMed ID: 9620301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
    Wang Y; Becker D
    Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
    Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
    Kinoshita I; Dosaka-Akita H; Mishina T; Akie K; Nishi M; Hiroumi H; Hommura F; Kawakami Y
    Cancer Res; 1996 Dec; 56(24):5557-62. PubMed ID: 8971152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p16 expression is associated with histological features of melanoma invasion.
    Pavey SJ; Cummings MC; Whiteman DC; Castellano M; Walsh MD; Gabrielli BG; Green A; Hayward NK
    Melanoma Res; 2002 Dec; 12(6):539-47. PubMed ID: 12459643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry.
    Sparrow LE; Eldon MJ; English DR; Heenan PJ
    Am J Dermatopathol; 1998 Jun; 20(3):255-61. PubMed ID: 9650698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression.
    Gruis NA; Weaver-Feldhaus J; Liu Q; Frye C; Eeles R; Orlow I; Lacombe L; Ponce-Castaneda V; Lianes P; Latres E
    Am J Pathol; 1995 May; 146(5):1199-206. PubMed ID: 7747814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of p16 protein expression in sporadic malignant melanoma.
    Grover R; Chana JS; Wilson GD; Richman PI; Sanders R
    Melanoma Res; 1998 Jun; 8(3):267-72. PubMed ID: 9664149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma.
    Straume O; Sviland L; Akslen LA
    Clin Cancer Res; 2000 May; 6(5):1845-53. PubMed ID: 10815907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.
    Kostaki M; Manona AD; Stavraka I; Korkolopoulou P; Levidou G; Trigka EA; Christofidou E; Champsas G; Stratigos AJ; Katsambas A; Papadopoulos O; Piperi C; Papavassiliou AG
    Exp Dermatol; 2014 May; 23(5):332-8. PubMed ID: 24673285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
    Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Stratigos A; Patereli A; Katsambas A
    J Cutan Pathol; 2008 Sep; 35(9):799-808. PubMed ID: 18494826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
    Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
    Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma.
    Kratzke RA; Otterson GA; Lincoln CE; Ewing S; Oie H; Geradts J; Kaye FJ
    J Natl Cancer Inst; 1995 Dec; 87(24):1870-5. PubMed ID: 7494231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.
    Glendening JM; Flores JF; Walker GJ; Stone S; Albino AP; Fountain JW
    Cancer Res; 1995 Dec; 55(23):5531-5. PubMed ID: 7585628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.